Neuroplast
PrivateLast Round
Series B
Nov 17, 2021
Total Funding Raised
$15.9M
Momentum Score
75 /100
Company Overview
Neuroplast is a biotechnology company that develops the autologous stem cell platform product Neuro-Cells®, a treatment to combat neurodegeneration resulting from trauma, disease and ageing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuroplast Comps
Public and private peers based on sector, stage, and business model.
Neuroplast Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 17, 2021 | ||||
| Series A | Feb 11, 2020 |
Neuroplast Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 819 Capital Partners | Series A |
| Brightlands Venture Partners | Series B, Series A |
| Lumana Invest | Series B |
| LIOF | Series B, Series A |
| Netherlands Enterprise Agency | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2026
Grew 43% QoQ from 7 to 10 employees.
Neuroplast Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuroplast's valuation, stock price, and market status.
